Krish Patel is a physician and clinical investigator at the Swedish Cancer Institute (SCI) in Seattle, Washington. His clinical and research interests are centered in the development of novel therapies for Non-Hodgkin Lymphomas. Dr. Patel completed his medical school, residency, and fellowship training at Duke University School of Medicine where he served as a Chief Resident in Internal Medicine. In 2016, he joined Dr. John Pagel’s hematology group at the Swedish Cancer Institute Center for Blood Disorders and Stem Cell Transplantation. He is currently a principal investigator for numerous active phase I-III therapeutic lymphoma clinical trials at SCI. In the clinic, he specializes in management of patients with all forms of NHL, but has a particular focus on stem cell transplantation and aggressive lymphoma histologies including DLBCL, Mantle cell lymphoma, transformed lymphomas, and T-cell lymphomas.